南京科佰生物科技有限公司
主营产品: atcc代理,ATCC细胞系,ATCC细胞株,ATCC细胞库购买 |
联系电话
南京科佰生物科技有限公司
主营产品: atcc代理,ATCC细胞系,ATCC细胞株,ATCC细胞库购买 |
联系电话
参考价 | 面议 |
更新时间:2022-07-28 16:44:31浏览次数:663
联系我们时请说明是化工仪器网上看到的信息,谢谢!
供货周期 | 现货 | 规格 | T-25 Flask |
---|---|---|---|
货号 | CBP74144 | 应用领域 | 生物产业 |
主要用途 | 仅限科研使用 |
CBP74144 | |
I. Background | |
The binding of Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated T cells, to its ligands, PD-L1 and PD-L2, negatively regulates immune responses. The PD-1 ligands are found on most cancers, and PD-1:PD-L1/2 interaction inhibits T cell activity and allows cancer cells to escape immune surveillance. The PD-1:PD-L1/2 pathway is also involved in regulating autoimmune responses, making these proteins promising therapeutic targets for a number of cancers, as well as multiple sclerosis, arthritis, lupus, and type I diabetes. | |
II. Introduction | |
Expressed gene: | PD1-IL2 |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin+800ug/ml hygromycin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Functional(Report Gene) Assay |
III. Representative Data | |
Figure 1. Dose Response of Anti-PD-L1 Blocking Antibody in PD-1-IL2 Pathway Effector Reporter Cells (C37) With Raji PD-L1 aAPC Cells. | |
Figure 2. Dose Response of Anti-PD-1 Blocking Antibody in PD-1-IL2 Pathway Effector Reporter Cells (C37) With Raji PD-L1 aAPC Cells. | |